Anti-IL-5 and hypereosinophilic syndromes

Clinical Immunology

Volumn 115, Issue 1 SPEC. ISS., 2005, Pages 51-60

  Sutton, Steven A ^a   Assa'ad, Amal H ^a   Rothenberg, Marc E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Anti IL 5; Anti interleukin 5; Eosinophilia; Hypereosinophilic syndromes; IL 5; Interleukin 5; Mepolizumab

Indexed keywords

ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; CHLORAMBUCIL; ETOPOSIDE; GLUCOCORTICOID; HYDROXYUREA; IMATINIB; INTERLEUKIN 5; MEPOLIZUMAB; MONOCLONAL ANTIBODY; RECOMBINANT ALPHA INTERFERON; SCH 55700; UNCLASSIFIED DRUG; VINCRISTINE;

CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GENETIC ANALYSIS; HUMAN; HYPEREOSINOPHILIC SYNDROME; LEUKOPENIA; MYALGIA; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; STANDARDIZATION;

EID: 18144405363     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.02.006     Document Type: Conference Paper

References (69)

1. P. Ehrlich Ueber die specifischen granulationen des blut Arch. Anat. Physiol., Lpz 1879 571 579
2. R. Stillman A case of myeloid leukemia with predominance of eosinophilic cells Med. Rec. 81 1912 594
3. R.E. Anderson, and W.R. Hardy Hypereosinophilia Ann. Intern. Med. 69 1968 1331 1332
4. F. Roufosse, L. Schandene, C. Sibille, K. Willard-Gallo, B. Kennes, A. Efira, M. Goldman, and E. Cogan Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome Br. J. Haematol. 109 2000 540 548
5. E. Cogan, L. Schandene, A. Crusiaux, P. Cochaux, T. Velu, and M. Goldman Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome N. Engl. J. Med. 330 1994 535 538
6. H.W. Chang, K.H. Leong, D.R. Koh, and S.H. Lee Clonality of isolated eosinophils in the hypereosinophilic syndrome Blood 93 1999 1651 1657
7. J. Cools, D.J. DeAngelo, J. Gotlib, E.H. Stover, R.D. Legare, J. Cortes, J. Kutok, J. Clark, I. Galinsky, J.D. Griffin, N.C. Cross, A. Tefferi, J. Malone, R. Alam, S.L. Schrier, J. Schmid, M. Rose, P. Vandenberghe, G. Verhoef, M. Boogaerts, I. Wlodarska, H. Kantarjian, P. Marynen, S.E. Coutre, R. Stone, and D.G. Gilliland A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome N. Engl. J. Med. 348 2003 1201 1214
8. M.J. Chusid, D.C. Dale, B.C. West, and S.M. Wolff The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature Medicine (Baltimore) 54 1975 1 27
9. A.H. Assa'ad, R.L. Spicer, D.P. Nelson, N. Zimmermann, and M.E. Rothenberg Hypereosinophilic syndromes Chem. Immunol. 76 2000 208 229
10. A.S. Fauci, J.B. Harley, W.C. Roberts, V.J. Ferrans, H.R. Gralnick, and B.H. Bjornson NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations Ann. Intern. Med. 97 1982 78 92
11. R. Virmani, P.K. Chun, B.E. Dunn, D. Hartmen, and H.A. McAllister Eosinophilic constrictive pericarditis Am. Heart J. 107 1984 803 807
12. C.Y. Chew, G.M. Ziady, M.J. Raphael, M. Nellen, and C.M. Oakley Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease Br. Heart J. 39 1977 399 413
13. P.V. Felice, J. Sawicki, and J. Anto Endomyocardial disease and eosinophilia Angiology 44 1993 869 874
14. M.B. Salzman, E. Valderrama, and S.K. Sood Carbamazepine and fatal eosinophilic myocarditis N. Engl. J. Med. 336 1997 878 879
15. B.F. Waller, L. Grider, T.M. Rohr, T. McLaughlin, C.P. Taliercio, and J. Fetters Intracardiac thrombi: frequency, location, etiology, and complications: a morphologic review-Part I Clin. Cardiol. 18 1995 477 479
16. W.G. Hendren, E.L. Jones, and M.D. Smith Aortic and mitral valve replacement in idiopathic hypereosinophilic syndrome Ann. Thorac. Surg. 46 1988 570 571
17. N.L. DePace, P.F. Nestico, J. Morganroth, J. Ross, R. Fox, M.N. Kotler, G.S. Mintz, and R. Vassallo Dilated cardiomyopathy in the idiopathic hypereosinophilic syndrome Am. J. Cardiol. 52 1983 1359 1360
18. C. Lefebvre, O. Bletry, P. Degoulet, L. Guillevin, M. Bentata-Pessayre, D. Le Thi Huong, and P. Godeau [Prognostic factors of hypereosinophilic syndrome. Study of 40 cases] Ann. Med. Interne (Paris) 140 1989 253 257
19. J.L. Naiman, F.A. Oski, F.H. Allen Jr., and L.K. Diamond Hereditary eosinophilia: report of a family and review of the literature Am. J. Hum. Genet. 16 1964 195 203
20. S.R. Wynn, M.I. Sachs, M.U. Keating, N.K. Ostrom, R.P. Kadota, E.J. O'Connell, and W.A. Smithson Idiopathic hypereosinophilic syndrome in a 5 1/2-month-old infant J. Pediatr. 111 1987 94 97
21. J.D. Rioux, V.A. Stone, M.J. Daly, M. Cargill, T. Green, H. Nguyen, T. Nutman, P.A. Zimmerman, M.A. Tucker, T. Hudson, A.M. Goldstein, E. Lander, and A.Y. Lin Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33 Am. J. Hum. Genet. 63 1998 1086 1094
22. F. Brito-Babapulle The eosinophilias, including the idiopathic hypereosinophilic syndrome Br. J. Haematol. 121 2003 203 223
23. K. Wilkinson, E.R. Velloso, L.F. Lopes, C. Lee, J.C. Aster, M.A. Shipp, and R.C. Aguiar Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib Blood 102 2003 4187 4190
24. K.J. Smith, E. Jacobson, S. Hamza, and H. Skelton Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses Arch. Dermatol. 140 2004 584 588
25. J.K. Doorduijn, K. van Lom, and B. Lowenberg Eosinophilia and granulocytic dysplasia terminating in acute myeloid leukaemia after 24 years Br. J. Haematol. 95 1996 531 534
26. M.E. Gershwin, L.F. Fajardo, M. Gurwith, and J.C. Kosek Eosinophilia terminating in myeloblastoma Am. J. Med. 53 1972 348 353
27. K.O. Goh, S.N. Swisher, and C.A. Rosenberg Cytogenetic studies in eosinophilic leukemia: the relationship of eosinophilic leukemia and chronic myelocytic leukemia Ann. Intern. Med. 62 1965 80 86
28. Y.L. Kwong, and L.C. Chan Involvement of eosinophils in acute myeloid leukaemia with monosomy 7 demonstrated by fluorescence in situ hybridization Br. J. Haematol. 88 1994 389 391
29. M. Luppi, R. Marasca, M. Morselli, P. Barozzi, and G. Torelli Clonal nature of hypereosinophilic syndrome Blood 84 1994 349 350
30. S. Molinier, B. Chaudier, P. Kraemer, B. Graffin, V.V. San, P. Imbert, M. Morillon, J.E. Touze, and C. Gras [Diagnostic and treatment of hypereosinophilia upon return from the tropics: 102 patients] Med. Trop. (Marseille) 58 1998 499 502
31. W. Hundt, A. Stabler, and M. Reiser MRI findings of muscle involvement in idiopathic hypereosinophilic syndrome Eur. Radiol. 9 1999 525 528
32. A.D. Klion, P. Noel, C. Akin, M.A. Law, D.G. Gilliland, J. Cools, D.D. Metcalfe, and T.B. Nutman Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness Blood 101 2003 4660 4666
33. T. Furitsu, T. Tsujimura, T. Tono, H. Ikeda, H. Kitayama, U. Koshimizu, H. Sugahara, J.H. Butterfield, L.K. Ashman, and Y. Kanayama Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product J. Clin. Invest. 92 1993 1736 1744
34. A. Pardanani, R.P. Ketterling, S.R. Brockman, H.C. Flynn, S.F. Paternoster, B.M. Shearer, T.L. Reeder, C.Y. Li, N.C. Cross, J. Cools, D.G. Gilliland, G.W. Dewald, and A. Tefferi CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy Blood 102 2003 3093 3096
35. A. Tefferi, A. Pardanani, and C.Y. Li Hypereosinophilic syndrome with elevated serum tryptase versus systemic mast cell disease associated with eosinophilia: 2 distinct entities? Blood 102 2003 3073 3074
36. B.J. Bain Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis Am. J. Hematol. 77 2004 82 85
37. K. Sakamoto, A. Erdreich-Epstein, Y. deClerck, and T. Coates Prolonged clinical response to vincristine treatment in two patients with idiopathic hypereosinophilic syndrome Am. J. Pediatr. Hematol./Oncol. 14 1992 348 351
38. P.F. Weller, and G.J. Bubley The idiopathic hypereosinophilic syndrome Blood 83 1994 2759 2779
39. E. Cofrancesco, M. Cortellaro, E. Pogliani, C. Boschetti, M. Salvatore, and E.E. Polli Response to vincristine treatment in a case of idiopathic hypereosinophilic syndrome with multiple clinical manifestations Acta Haematol. 72 1984 21 25
40. T.Y. Yoon, G.B. Ahn, and S.H. Chang Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review J. Dermatol. 27 2000 110 115
41. J.H. Butterfield, and G.J. Gleich Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa J. Allergy Clin. Immunol. 94 1994 1318 1326
42. J.H. Butterfield, and G.J. Gleich Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome Ann. Intern. Med. 121 1994 648 653
43. H.E. Broxmeyer, S. Cooper, B.Y. Rubin, and M.W. Taylor The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro J. Immunol. 135 1985 2502 2506
44. S. Nadarajah, B. Krafchik, C. Roifman, and C. Horgan-Bell Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality Pediatrics 99 1997 630 633
45. G.J. Gleich, K.M. Leiferman, A. Pardanani, A. Tefferi, and J.H. Butterfield Treatment of hypereosinophilic syndrome with imatinib mesilate Lancet 359 2002 1577 1578
46. J.L. Schaller, and G.A. Burkland Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate Med. Gen. Med. 3 2001 9
47. A. Pardanani, T. Reeder, L.F. Porrata, C.Y. Li, H.D. Tazelaar, E.J. Baxter, T.E. Witzig, N.C. Cross, and A. Tefferi Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders Blood 101 2003 3391 3397
48. E. Archimbaud, D. Guyotat, C. Guillaume, J. Godard, and D. Fiere Hypereosinophilic syndrome with multiple organ dysfunction treated by allogeneic bone marrow transplantation Am. J. Hematol. 27 1988 302 303
49. N.T. Ueno, A. Anagnostopoulos, G. Rondon, R.E. Champlin, N. Mikhailova, O.S. Pankratova, L.S. Zoubarovskaya, E.V. Semenova, B.V. Afanasyev, S. O'Brien, M. Andreeff, and A.Y. Zaritskey Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome Br. J. Haematol. 119 2002 131 134
50. C.J. Sanderson Interleukin-5, eosinophils, and disease Blood 79 1992 3101 3109
51. A.N. McKenzie, B. Ely, and C.J. Sanderson Mutated interleukin-5 monomers are biologically inactive Mol. Immunol. 28 1991 155 158
52. J. Tavernier, R. Devos, S. Cornelis, T. Tuypens, J. Van der Heyden, W. Fiers, and G. Plaetinck A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF Cell 66 1991 1175 1184
53. T. Kitamura, N. Sato, K. Arai, and A. Miyajima Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors Cell 66 1991 1165 1174
54. J.C. Kips, B.J. O'Connor, S.J. Langley, A. Woodcock, H.A. Kerstjens, D.S. Postma, M. Danzig, F. Cuss, and R.A. Pauwels Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study Am. J. Respir. Crit. Care Med. 167 2003 1655 1659
55. P.T. Flood-Page, A.N. Menzies-Gow, A.B. Kay, and D.S. Robinson Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway Am. J. Respir. Crit. Care Med. 167 2003 199 204
56. M.J. Leckie, A. ten Brinke, J. Khan, Z. Diamant, B.J. O'Connor, C.M. Walls, A.K. Mathur, H.C. Cowley, K.F. Chung, R. Djukanovic, T.T. Hansel, S.T. Holgate, P.J. Sterk, and P.J. Barnes Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2144 2148
57. J. Zhang, R. Kuvelkar, N.J. Murgolo, S.S. Taremi, C.C. Chou, P. Wang, M.M. Billah, and R.W. Egan Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5 Int. Immunol. 11 1999 1935 1944
58. P. Zia-Amirhosseini, E. Minthorn, L.J. Benincosa, T.K. Hart, C.S. Hottenstein, L.A. Tobia, and C.B. Davis Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys J. Pharmacol. Exp. Ther. 291 1999 1060 1067
59. A.D. Klion, M.A. Law, P. Noel, Y.J. Kim, T.P. Haverty, and T.B. Nutman Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome Blood 103 2004 2939 2941
60. J.K. Garrett, S.C. Jameson, B. Thomson, M.H. Collins, L.E. Wagoner, D.K. Freese, L.A. Beck, J.A. Boyce, A.H. Filipovich, J.M. Villanueva, S.A. Sutton, A.H. Assa'ad, and M.E. Rothenberg Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes J. Allergy Clin. Immunol. 113 2004 115 119
61. T.K. Hart, R.M. Cook, P. Zia-Amirhosseini, E. Minthorn, T.S. Sellers, B.E. Maleeff, S. Eustis, L.W. Schwartz, P. Tsui, E.R. Appelbaum, E.C. Martin, P.J. Bugelski, and D.J. Herzyk Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys J. Allergy Clin. Immunol. 108 2001 250 257
62. P. Flood-Page, A. Menzies-Gow, S. Phipps, S. Ying, A. Wangoo, M.S. Ludwig, N. Barnes, D. Robinson, and A.B. Kay Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics J. Clin. Invest. 112 2003 1029 1036
63. D.S. Robinson, Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A.M. Bentley, C. Corrigan, S.R. Durham, and A.B. Kay Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma N. Engl. J. Med. 326 1992 298 304
64. B. Lamkhioued, P.M. Renzi, S. Abi-Younes, E.A. Garcia-Zepada, Z. Allakhverdi, O. Ghaffar, M.D. Rothenberg, A.D. Luster, and Q. Hamid Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation J. Immunol. 159 1997 4593 4601
65. B. Gregory, A. Kirchem, S. Phipps, P. Gevaert, C. Pridgeon, S.M. Rankin, and D.S. Robinson Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression J. Immunol. 170 2003 5359 5366
66. S.G. Plotz, H.U. Simon, U. Darsow, D. Simon, E. Vassina, S. Yousefi, R. Hein, T. Smith, H. Behrendt, and J. Ring Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis N. Engl. J. Med. 349 2003 2334 2339
67. Y.J. Kim, C. Prussin, B. Martin, M.A. Law, T.P. Haverty, T.B. Nutman, and A.D. Klion Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700 J. Allergy Clin. Immunol. 114 2004 1449 1455
68. P. Valent, H.P. Horny, L. Escribano, B.J. Longley, C.Y. Li, L.B. Schwartz, G. Marone, R. Nunez, C. Akin, K. Sotlar, W.R. Sperr, K. Wolff, R.D. Brunning, R.M. Parwaresch, K.F. Austen, K. Lennert, D.D. Metcalfe, J.W. Vardiman, and J.M. Bennett Diagnostic criteria and classification of mastocytosis: a consensus proposal Leuk. Res. 25 2001 603 625
69. H.N. Vardiman E.S. Jaffe H. Stein J.W. Vardiman World Health Organization classification of tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues 2001 IA.R.C. Press Lyon, France 17 31 (47-52)